BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10507774)

  • 1. The expression of thymidine phosphorylase correlates with angiogenesis and the efficacy of chemotherapy using fluorouracil derivatives in advanced gastric carcinoma.
    Saito H; Tsujitani S; Oka S; Kondo A; Ikeguchi M; Maeta M; Kaibara N
    Br J Cancer; 1999 Oct; 81(3):484-9. PubMed ID: 10507774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoangiogenesis in patients with gastric carcinoma in relation to the expression of vascular endothelial growth factor and thymidine phosphorylase.
    Tsujitani S; Saito H; Maeta Y; Yamaguchi K; Tatebe S; Kondo A; Kaibara N
    Anticancer Res; 2004; 24(3b):1853-9. PubMed ID: 15274366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidine phosphorylase expression in gastric cancer in association with proliferative activity and angiogenesis.
    Kikuyama S; Inada T; Shimizu K; Miyakita M
    Anticancer Res; 2000; 20(3B):2081-6. PubMed ID: 10928156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase, E2F-1, Bak, Bcl-X, and Bcl-2, and clinical outcomes for gastric cancer patients treated with bolus 5-fluorouracil.
    Tahara M; Ochiai A; Fujimoto J; Boku N; Yasui W; Ohtsu A; Tahara E; Yoshida S
    Oncol Rep; 2004 Jan; 11(1):9-15. PubMed ID: 14654896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of thymidine phosphorylase in human cervical cancer.
    Hata K; Takebayashi Y; Iida K; Fujiwaki R; Fukumoto M; Miyazaki K
    Anticancer Res; 1999; 19(1B):709-16. PubMed ID: 10216481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer.
    Chen CN; Hsieh FJ; Cheng YM; Chang KJ; Lee PH
    J Surg Oncol; 2006 Sep; 94(3):226-33. PubMed ID: 16900533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of thymidine phosphorylase levels in cancer, background mucosa, and regional lymph nodes on survival of advanced gastric cancer patients receiving postoperative fluoropyrimidine therapy.
    Kosaka T; Usami K; Ueshige N; Sugaya J; Nakano Y; Takashima S
    Oncol Rep; 2004 Dec; 12(6):1279-86. PubMed ID: 15547751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
    Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
    Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis in gastric cancer: importance of the thymidine phosphorylase expression of cancer cells as an angiogenic factor.
    Han HS; Hwang TS
    Oncol Rep; 2007 Jan; 17(1):61-5. PubMed ID: 17143479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy.
    Koukourakis MI; Giatromanolaki A; Fountzilas G; Sivridis E; Gatter KC; Harris AL
    Clin Cancer Res; 2000 Feb; 6(2):381-9. PubMed ID: 10690514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of thymidine phosphorylase expression in tumor stroma as a prognostic factor in patients with advanced colorectal carcinoma.
    Yasuno M; Mori T; Koike M; Takahashi K; Toi M; Takizawa T; Shimizu S; Yamaguchi T; Matsumoto H
    Oncol Rep; 2005 Mar; 13(3):405-12. PubMed ID: 15706408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relation of heparanase mRNA expression and angiogenesis to the progression of gastric carcinoma].
    Ren XL; Zhu RZ; Wang LJ; Zhang ML; Li DH; Deng XQ
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):368-71. PubMed ID: 12921569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of thymidine phosphorylase expression in the invasiveness of gastric carcinoma.
    Shimaoka S; Matsushita S; Nitanda T; Matsuda A; Nioh T; Suenaga T; Nishimata Y; Akiba S; Akiyama S; Nishimata H
    Cancer; 2000 May; 88(10):2220-7. PubMed ID: 10820342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and prognostic significance of thymidine phosphorylase expression in gastric carcinoma.
    Ogawa K; Konno S; Takebayashi Y; Miura K; Katsube T; Kajiwara T; Aiba M; Aikou T; Akiyama S
    Anticancer Res; 1999; 19(5C):4363-7. PubMed ID: 10650777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidine phosphorylase expression in gastric carcinoma as a marker for metastasis.
    Konno S; Takebayashi Y; Higashimoto M; Katsube T; Kanzaki A; Kawahara M; Takenoshita S; Aiba M; Ogawa K
    Anticancer Res; 2003; 23(6D):5011-4. PubMed ID: 14981960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine.
    Tokunaga Y; Takahashi K; Saito T
    Hepatogastroenterology; 2005; 52(66):1715-21. PubMed ID: 16334763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53, bcl-2 and thymidine phosphorylase as predictive markers of chemotherapy in patients with advanced and recurrent gastric cancer.
    Kikuyama S; Inada T; Shimizu K; Miyakita M; Ogata Y
    Anticancer Res; 2001; 21(3C):2149-53. PubMed ID: 11501839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary evaluation of adjuvant chemotherapy against stage Ib or II gastric cancer].
    Inada T; Kawakubo H; Ichikawa A; Ogata Y
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):315-20. PubMed ID: 10065094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
    Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
    J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.